JPWO2021247608A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021247608A5 JPWO2021247608A5 JP2023517830A JP2023517830A JPWO2021247608A5 JP WO2021247608 A5 JPWO2021247608 A5 JP WO2021247608A5 JP 2023517830 A JP2023517830 A JP 2023517830A JP 2023517830 A JP2023517830 A JP 2023517830A JP WO2021247608 A5 JPWO2021247608 A5 JP WO2021247608A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- seq
- set forth
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063032886P | 2020-06-01 | 2020-06-01 | |
| US63/032,886 | 2020-06-01 | ||
| US17/199,258 | 2021-03-11 | ||
| US17/199,258 US11976120B2 (en) | 2020-06-01 | 2021-03-11 | Antibodies targeting a complex comprising non-classical HLA-I and neoantigen and their methods of use |
| PCT/US2021/035291 WO2021247608A1 (en) | 2020-06-01 | 2021-06-01 | Antibodies targeting a complex comprising non-classical hla-i and neoantigen and their methods of use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023530037A JP2023530037A (ja) | 2023-07-12 |
| JPWO2021247608A5 true JPWO2021247608A5 (es) | 2023-08-03 |
Family
ID=78829884
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023517830A Pending JP2023530037A (ja) | 2020-06-01 | 2021-06-01 | 非古典的ｈｌａ－ｉとネオアンチゲンとを含む複合体を標的とする抗体、およびその使用方法 |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US11976120B2 (es) |
| EP (1) | EP4157884A4 (es) |
| JP (1) | JP2023530037A (es) |
| KR (1) | KR20230019469A (es) |
| CN (1) | CN116157157A (es) |
| AU (1) | AU2021283201A1 (es) |
| BR (1) | BR112022023933A2 (es) |
| CA (1) | CA3174102A1 (es) |
| CL (1) | CL2022003299A1 (es) |
| CO (1) | CO2022018430A2 (es) |
| CR (1) | CR20220650A (es) |
| DO (1) | DOP2022000265A (es) |
| EC (1) | ECSP22097203A (es) |
| IL (1) | IL298061A (es) |
| MX (1) | MX2022015129A (es) |
| PE (1) | PE20230374A1 (es) |
| WO (1) | WO2021247608A1 (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2019309948A1 (en) * | 2018-07-23 | 2021-02-25 | Boehringer Ingelheim Pharmaceuticals, Inc. | Antibodies targeting a complex comprising non-classical HLA-I and neoantigen and their methods of use |
| US10981996B1 (en) * | 2020-06-01 | 2021-04-20 | Abexxa Biologics, Inc. | Antibodies targeting a complex comprising non-classical HLA-I and neoantigen and their methods of use |
| US11976120B2 (en) | 2020-06-01 | 2024-05-07 | Boehringer Ingelheim International Gmbh | Antibodies targeting a complex comprising non-classical HLA-I and neoantigen and their methods of use |
| WO2023150092A2 (en) * | 2022-02-01 | 2023-08-10 | University Of Pittsburgh – Of The Commonwealth System Of Higher Education | Molecules that bind to cd276 polypeptides |
| TW202413410A (zh) * | 2022-08-18 | 2024-04-01 | 英商英美偌科有限公司 | 多域結合分子 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1790664A1 (en) | 2005-11-24 | 2007-05-30 | Ganymed Pharmaceuticals AG | Monoclonal antibodies against claudin-18 for treatment of cancer |
| EP2998320B1 (en) | 2011-04-19 | 2018-07-18 | The United States of America, as represented by the Secretary, Department of Health and Human Services | Human monoclonal antibodies specific for glypican-3 and use thereof |
| US10656156B2 (en) | 2012-07-05 | 2020-05-19 | Mepur Ravindranath | Diagnostic and therapeutic potential of HLA-E monospecific monoclonal IgG antibodies directed against tumor cell surface and soluble HLA-E |
| WO2014131711A1 (en) | 2013-02-26 | 2014-09-04 | Roche Glycart Ag | Bispecific t cell activating antigen binding molecules |
| WO2015095392A1 (en) * | 2013-12-17 | 2015-06-25 | Genentech, Inc. | Anti-cd3 antibodies and methods of use |
| CN103773775B (zh) | 2014-01-26 | 2015-11-18 | 江苏省农业科学院 | 一种人源抗虫基因及其编码的抗Cry1B毒素独特型单链抗体与应用 |
| JP2017528418A (ja) | 2014-06-20 | 2017-09-28 | バイオアライアンス コマンディテール フェンノートシャップ | 抗葉酸受容体アルファ（ｆｒａ）抗体−薬物コンジュゲート及びその使用方法 |
| EP3209687A1 (en) | 2014-10-23 | 2017-08-30 | Innate Pharma | Treatment of cancers using anti-nkg2a agents |
| SG11201705496SA (en) | 2015-01-08 | 2017-08-30 | Genmab As | Bispecific antibodies against cd3 and cd20 |
| MA45491A (fr) | 2016-06-27 | 2019-05-01 | Juno Therapeutics Inc | Épitopes à restriction cmh-e, molécules de liaison et procédés et utilisations associés |
| EP3573997A4 (en) | 2017-01-24 | 2020-12-09 | Abexxa Biologics, Inc. | METHODS AND COMPOSITIONS INTENDED TO TARGE A COMPLEX INCLUDING A NON-CLASSIC HLA-I AND A NEO-ANTIGEN IN THE TREATMENT OF CANCER |
| EP3755371A4 (en) | 2018-02-23 | 2021-11-24 | Abexxa Biologics, Inc. | ANTI-CANCER TREATMENT COMBINED WITH ANTI-CANCER AGENTS AND ANTIBODIES TARGETING A COMPLEX INCLUDING A NON-CLASSIC HLA-I AND A NEO-ANTIGEN |
| AU2019309948A1 (en) | 2018-07-23 | 2021-02-25 | Boehringer Ingelheim Pharmaceuticals, Inc. | Antibodies targeting a complex comprising non-classical HLA-I and neoantigen and their methods of use |
| US20200291128A1 (en) | 2020-05-18 | 2020-09-17 | Abexxa Biologics, Inc. | Antibodies and methods of use thereof |
| US10981996B1 (en) | 2020-06-01 | 2021-04-20 | Abexxa Biologics, Inc. | Antibodies targeting a complex comprising non-classical HLA-I and neoantigen and their methods of use |
| US10981997B1 (en) * | 2020-06-01 | 2021-04-20 | Abexxa Biologics, Inc. | Antibodies targeting a complex comprising non-classical HLA-I and neoantigen and their methods of use |
| US11976120B2 (en) | 2020-06-01 | 2024-05-07 | Boehringer Ingelheim International Gmbh | Antibodies targeting a complex comprising non-classical HLA-I and neoantigen and their methods of use |
-
2021
- 2021-03-11 US US17/199,258 patent/US11976120B2/en active Active
- 2021-06-01 IL IL298061A patent/IL298061A/en unknown
- 2021-06-01 MX MX2022015129A patent/MX2022015129A/es unknown
- 2021-06-01 JP JP2023517830A patent/JP2023530037A/ja active Pending
- 2021-06-01 PE PE2022002747A patent/PE20230374A1/es unknown
- 2021-06-01 BR BR112022023933A patent/BR112022023933A2/pt not_active Application Discontinuation
- 2021-06-01 EP EP21818757.3A patent/EP4157884A4/en active Pending
- 2021-06-01 US US18/000,493 patent/US20230303701A1/en active Pending
- 2021-06-01 WO PCT/US2021/035291 patent/WO2021247608A1/en active Application Filing
- 2021-06-01 CN CN202180057675.8A patent/CN116157157A/zh active Pending
- 2021-06-01 CA CA3174102A patent/CA3174102A1/en active Pending
- 2021-06-01 CR CR20220650A patent/CR20220650A/es unknown
- 2021-06-01 KR KR1020227046390A patent/KR20230019469A/ko unknown
- 2021-06-01 AU AU2021283201A patent/AU2021283201A1/en active Pending
-
2022
- 2022-11-24 DO DO2022000265A patent/DOP2022000265A/es unknown
- 2022-11-24 CL CL2022003299A patent/CL2022003299A1/es unknown
- 2022-12-19 CO CONC2022/0018430A patent/CO2022018430A2/es unknown
- 2022-12-23 EC ECSENADI202297203A patent/ECSP22097203A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020055853A5 (es) | ||
| JP2019536430A5 (es) | ||
| JP2020063262A5 (es) | ||
| JP2017048240A5 (es) | ||
| JP2017535257A5 (es) | ||
| JP2019535763A5 (es) | ||
| JP2017500057A5 (es) | ||
| RU2018124319A (ru) | Новые антитела к клаудину и способы их применения | |
| JP2022101693A5 (es) | ||
| JP2017186337A5 (es) | ||
| JP2009521496A5 (es) | ||
| JP2013527761A5 (es) | ||
| JP2022105495A5 (es) | ||
| JP2013527762A5 (es) | ||
| JP2020502271A5 (es) | ||
| JP2009225799A5 (es) | ||
| JP2019524701A5 (es) | ||
| WO2020257789A3 (en) | Anti-tim-3 antibodies | |
| JPWO2021247608A5 (es) | ||
| JP2002529054A5 (es) | ||
| JPWO2022114163A5 (es) | ||
| JPWO2021247607A5 (es) | ||
| JPWO2021104371A5 (es) | ||
| JPWO2019204564A5 (es) | ||
| JP2020527594A5 (es) |